BioStock and the co-organizers SDS Life Science and DNB welcomed around a hundred specially invited guests to the World Trade Center in Stockholm on Thursday. The event provided an opportunity for entrepreneurs and investors in life sciences to network, discuss and exchange experiences on a range of current topics.
The keynote speakers made an impression
One of the keynote speakers, the brand expert Cecilia Perlind, emphasized the importance of a sustainable brand strategy and how a strong brand can contribute to the growth of a company.
Today's second keynote speaker, economist and author Kjell A Nordstrom, highlighted external factors and trends we have to deal with. He discussed various strategic choices life science companies need to make to be successful in a changing environment. He also highlighted the value of successfully establishing “temporary monopolies” in the market. Companies in the life science world can usually achieve this with the help of a strong IP portfolio, but also through groundbreaking innovations.
Strong premiere with many participants
The program also included presentations and panel discussions with specialized life science investors such as Healthcap, Flerie Invest, Linz, Sound Bioventures and Almi Invest. The speaker list also included company leaders who shared with the audience their own experiences of, among other things, partnering and commercialization with a focus on the US market.
One of these, Martin Amark, CEO of Xbrane Biopharma, we caught up in a short interview. During the event, Åmark spoke about how Xbrane has been actively working on partnering strategies since day one. The audience heard about the work behind the various collaboration agreements the company has managed to close over the years.
See the interview with Xbrane Biopharma's Martin Åmark below.
See the event program in its entirety here.
Expressions of interest to participate in upcoming Executive Insights can be made to insights [@] biostock.se.